Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)
      Description

      This study aimed to investigate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastrointestinal (GI), or thoracic origin or poorly-differentiated gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC) that progressed on prior treatment.

      Conditions
      Well-differentiated Non-functional NET of Thoracic OriginWell-differentiated Non-functional NET of Gastrointestinal OriginWell-differentiated Non-functional NET of Pancreatic OriginPoorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma
      Talk to us
      COMPLETED
      KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors
      Description

      Evaluate the efficacy of Selinexor in patients with poorly differentiated lung and gastrointestinal and pancreatic neuroendocrine tumors.

      Conditions
      Carcinoma, Neuroendocrine
      Talk to us